Lexaria Bioscience's total assets for Q2 2025 were $8.68M, a decrease of -11.40% from the previous quarter. LEXX total liabilities were $1.92M for the fiscal quarter, a 379.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.